Search research articles
Contact Us
Filters
Showing results (291-300 of 339) with videos related to
Page
of 34
Sort By:
Gut
|
January 4, 2011
Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
Hephzibah Rani S Tagaram, Nicole A Divittore, Brian M Barth, et al.
Genes & Development
|
December 19, 2007
beta-Catenin is a Nek2 substrate involved in centrosome separation
Shirin Bahmanyar, Daniel D Kaplan, Jennifer G Deluca, et al.
Children'S Health Care : Journal of the Association for the Care of Children'S Health
|
May 9, 2022
A Qualitative Inquiry of Parents' Observations of Their Children's Mental Health Needs During the COVID-19 Pandemic
Alexandra M Barth, Allison C Meinert, Katherine L Zopatti, et al.
Clinical Genetics
|
June 4, 2014
Mutation update and uncommon phenotypes in a French cohort of 96 patients with WFS1-related disorders
A Chaussenot, C Rouzier, M Quere, et al.
Vaccine
|
August 27, 2005
Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence
Simone M Costa, Marciano V Paes, Débora F Barreto, et al.
ACS Nano
|
February 26, 2010
Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo
Brian M Barth, Rahul Sharma, Erhan I Altinoğlu, et al.
Science (New York, N.Y.)
|
January 23, 2025
Identification of the subventricular tegmental nucleus as brainstem reward center
Krisztián Zichó, Boldizsár Zsolt Balog, Réka Z Sebestény, et al.
Nature
|
August 30, 2000
The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells
P J Coopman, M T Do, M Barth, et al.
Plos One
|
November 29, 2016
Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy
Sharon M Barth, Christian M Schreitmüller, Franziska Proehl, et al.
Leukemia
|
September 4, 2012
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report
S Goldman, L Smith, J R Anderson, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 339) with videos related to
Sort By:
Page
of 34
Gut
|
January 4, 2011
Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
Hephzibah Rani S Tagaram, Nicole A Divittore, Brian M Barth, et al.
Genes & Development
|
December 19, 2007
beta-Catenin is a Nek2 substrate involved in centrosome separation
Shirin Bahmanyar, Daniel D Kaplan, Jennifer G Deluca, et al.
Children'S Health Care : Journal of the Association for the Care of Children'S Health
|
May 9, 2022
A Qualitative Inquiry of Parents' Observations of Their Children's Mental Health Needs During the COVID-19 Pandemic
Alexandra M Barth, Allison C Meinert, Katherine L Zopatti, et al.
Clinical Genetics
|
June 4, 2014
Mutation update and uncommon phenotypes in a French cohort of 96 patients with WFS1-related disorders
A Chaussenot, C Rouzier, M Quere, et al.
Vaccine
|
August 27, 2005
Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence
Simone M Costa, Marciano V Paes, Débora F Barreto, et al.
ACS Nano
|
February 26, 2010
Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo
Brian M Barth, Rahul Sharma, Erhan I Altinoğlu, et al.
Science (New York, N.Y.)
|
January 23, 2025
Identification of the subventricular tegmental nucleus as brainstem reward center
Krisztián Zichó, Boldizsár Zsolt Balog, Réka Z Sebestény, et al.
Nature
|
August 30, 2000
The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells
P J Coopman, M T Do, M Barth, et al.
Plos One
|
November 29, 2016
Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy
Sharon M Barth, Christian M Schreitmüller, Franziska Proehl, et al.
Leukemia
|
September 4, 2012
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report
S Goldman, L Smith, J R Anderson, et al.
Page
of 34